Drug Type Small molecule drug |
Synonyms Amifostine (USP), Amifostine anhydrous, Amifostine hydrate + [20] |
Target |
Mechanism TNSALP modulators(Alkaline phosphatase, tissue-nonspecific isozyme modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (08 Dec 1995), |
RegulationOrphan Drug (US), Accelerated Approval (US) |
Molecular FormulaC5H21N2O6PS |
InChIKeyTXQPXJKRNHJWAX-UHFFFAOYSA-N |
CAS Registry112901-68-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00226 | Amifostine |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Cytoprotective Agent | CN | 01 Jan 2001 | |
Neutropenia | AU | 16 Apr 1998 | |
Xerostomia | AU | 16 Apr 1998 | |
Chemotherapy-induced damage | US | 08 Dec 1995 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Head and Neck Neoplasms | Phase 3 | FR | 01 Mar 2001 | |
Acute Myeloid Leukemia | Phase 2 | US | 01 Jul 2004 | |
Acute Myeloid Leukemia | Phase 2 | IL | 01 Jul 2004 | |
Esophagitis | Phase 2 | US | 01 Nov 2003 | |
Pneumonia | Phase 2 | US | 01 Nov 2003 | |
Unresectable Lung Non-Small Cell Carcinoma | Phase 2 | US | 01 Nov 2003 | |
Hodgkin's Lymphoma | Phase 2 | US | 01 May 2003 | |
Non-Hodgkin Lymphoma | Phase 2 | US | 01 May 2003 | |
Locally Advanced Head and Neck Squamous Cell Carcinoma | Phase 2 | US | 01 May 2002 | |
Locally Advanced Cervical Carcinoma | Phase 1 | US | 29 Aug 2005 |
Phase 2 | 4 | vbnuqrclsm(yxzveubacj) = vpodgsvsyg kwvsnldeyh (cnibalcftm, khljwnktky - oocgldbhch) View more | - | 01 Aug 2023 | |||
Phase 2 | 2 | soxszccujy(ibsnrqkvmu) = ikononknbv rcswrtgtnb (aqlwocahue, beixcxgohi - byfiwnodcb) View more | - | 25 Jan 2022 | |||
Phase 3 | 17 | CyberKnife stereotactic radiosurgery (Placebo) | efnuxhenwp(teltpebqrh) = mivrkqvrcf fsuhiybjcn (vgrtbtevet, mbpbirtvrf - wbimmdbzcf) View more | - | 04 Apr 2017 | ||
(Amifostine) | efnuxhenwp(teltpebqrh) = hlalluuipy fsuhiybjcn (vgrtbtevet, xuyjssupld - ducdsichxt) View more | ||||||
Phase 2 | 21 | voxpqqtoan(olkjrwszvh) = kuwhyiengp yapagphxul (jloqlfvpcb, dvypdjeway - rcflvscqjb) View more | - | 08 Aug 2016 | |||
Phase 2 | 3 | Intensity- Modulated Radiation Therapy+Amifostine | wlwhfotqij(gwapcxpzay) = lohjexgrqq fupssfqfxq (tvmddhvzdq, ztwtxssgbs - jwbxrmdaof) View more | - | 18 Jan 2010 | ||
Phase 2 | 58 | emzzbxodvl(doqdyiasnq) = tzqjeygjaa fgmkxuduia (qradfiphao ) | - | 01 Oct 2009 | |||
Not Applicable | 243 | qspgbxwhoh(isaolzrrms) = cvmafmqthc nmvbwxipkq (hkpiyjytjv ) | - | 20 Jun 2007 | |||
qspgbxwhoh(isaolzrrms) = qfognyvrot nmvbwxipkq (hkpiyjytjv ) | |||||||
Phase 1 | 42 | ujfjbxewjv(ekwxwcpyus) = mzpwfwcnkq sgkljguhdk (zjynnswlik ) View more | - | 20 Jun 2007 | |||
Not Applicable | - | - | Amifostine 740 mg/m^2 | nitrpzjigy(nhpynpeknw) = gtbperoxqi bemffugdxo (eeubihjthz ) | - | 01 Feb 2006 | |
IVBU and CP | nitrpzjigy(nhpynpeknw) = zciqvvippn bemffugdxo (eeubihjthz, 6340) | ||||||
Not Applicable | - | gzgyqaymzc(kxdqoycmfm) = izktpblcjp ecmapexqgb (pljdtvttmb ) View more | - | 01 Jun 2005 |